Announcements Trials
Browse Landscape

Phase

Phase NA 5Phase 2 2Phase EARLY_PHASE1 1Phase 3 1Phase 1/2 1

Status

Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Carcinoma, Non-Small-Cell Lung 8Squamous Cell Carcinoma of Head and Neck 6Lung Neoplasms 4Head and Neck Neoplasms 4Glioblastoma 4Pancreatic Neoplasms 3Gliosarcoma 3Brain Neoplasms 3Stomach Neoplasms 2Rectal Neoplasms 2Prostatic Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Carcinoma 2Central Nervous System Neoplasms 2Breast Neoplasms 2Adenocarcinoma of Lung 2Vulvar Neoplasms 1Vomiting 1Urinary Bladder Neoplasms 1Stage II Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Solitary Fibrous Tumor, Pleural 1Sarcoma 1Salivary Gland Neoplasms 1Radiodermatitis 1Pleural Effusion, Malignant 1Ovarian Neoplasms 1Osteosarcoma 1Optic Nerve Glioma 1Oligodendroglioma 1Nausea 1

Interventions

Trastuzumab 304Paclitaxel 257Cyclophosphamide 251Docetaxel 238Capecitabine 176Letrozole 163Carboplatin 163Fulvestrant 145Doxorubicin 145Bevacizumab 121Anastrozole 106Tamoxifen 102exemestane 94Vinorelbine 91Epirubicin 90pertuzumab 89Gemcitabine 84Lapatinib 80Albumin-Bound Paclitaxel 74Radiotherapy 71pembrolizumab 70palbociclib 64130-nm albumin-bound paclitaxel 58eribulin 56Cisplatin 55Everolimus 49pyrotinib 45Taxes 44Goserelin 43Neoadjuvant Therapy 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Breast Neoplasms × Radiotherapy, Conformal × Clear all
NCT02142959 2025-06-03

RTA 408 Lotion in Patients at Risk for Radiation Dermatitis - PRIMROSE

Biogen

Phase 2 Completed
187 enrolled 11 charts
Breast

Breast Neoplasms, Inflammation, Radiodermatitis

NCT02453737 2024-09-19

A Study of Accelerated 3 Fraction Photon,Proton or Brachytherapy for Early Invasive and Noninvasive Breast Ca

Mayo Clinic

Phase 2 Completed
170 enrolled 16 charts
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡